Differential expression of activator protein-2 isoforms in renal cell carcinoma

Urology

Volumn 64, Issue 1, 2004, Pages 162-167

  Oya, Mototsugu ^a   Mikami, Shuji ^a   Mizuno, Ryuichi ^a   Miyajima, Akira ^a   Horiguchi, Yutaka ^a   Nakashima, Jun ^a   Marumo, Ken ^a   Mukai, Makio ^a   Murai, Masaru ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ISOPROTEIN; TRANSCRIPTION FACTOR AP 2;

ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY TUBULE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING;

ADENOCARCINOMA; ADENOCARCINOMA, CLEAR CELL; CARCINOMA, PAPILLARY; CARCINOMA, RENAL CELL; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KIDNEY NEOPLASMS; KIDNEY TUBULES; NEOPLASM PROTEINS; NEOPLASM STAGING; PROTEIN ISOFORMS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; TRANSCRIPTION FACTOR AP-2; TRANSCRIPTION FACTORS;

EID: 3042696396     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urology.2004.02.022     Document Type: Article

References (22)

1. Negrier S., Caty A., Lesimple T., et al. for the Groupe Francais d'Immunotherapie, Federation Nationale des Centres de Lutte Contre le Cancer Treatment of patients with metastatic renal carcinoma with a combination of subcutaneous interleukin-2 and interferon alfa with or without fluorouracil. J Clin Oncol. 18:2000;4009-4015
2. Freeman M.R., Washecka R., Chung L.W. Aberrant expression of epidermal growth factor receptor and HER-2 (erbB-2) messenger RNAs in human renal cancers. Cancer Res. 49:1989;6221-6225
3. Stumm G., Eberwein S., Rostock-Wolf S., et al. Concomitant overexpression of the EGFR and erbB-2 genes in renal cell carcinoma (RCC) is correlated with dedifferentiation and metastasis. Int J Cancer. 69:1996;17-22
4. Rotter M., Block T., Busch R., et al. Expression of HER-2/neu in renal-cell carcinoma correlation with histologic subtypes and differentiation. Int J Cancer. 52:1992;213-217
5. Bosher J.M., Williams T., Hurst H.C. The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma. Proc Natl Acad Sci USA. 92:1995;744-747
6. Bosher J.M., Totty N.F., Hsuan J.J., et al. A family of AP-2 proteins regulates c-erbB-2 expression in mammary carcinoma. Oncogene. 13:1996;1701-1707
7. Gee J.M., Robertson J.F., Ellis I.O., et al. Immunohistochemical analysis reveals a tumour suppressor-like role for the transcription factor AP-2 in invasive breast cancer. J Pathol. 189:1999;514-520
8. Bar-Eli M. Molecular mechanisms of melanoma metastasis. J Cell Physiol. 173:1997;275-278
9. Anttila M.A., Kellokoski J.K., Moisio K.I., et al. Expression of transcription factor AP-2α predicts survival in epithelial ovarian cancer. Br J Cancer. 82:2000;1974-1983
10. Ropponen K.M., Kellokoski J.K., Lipponen P.K., et al. p22/WAF1 expression in human colorectal carcinoma association with p53, transcription factor AP-2 and prognosis. Br J Cancer. 81:1999;133-140
11. Zeng Y.X., Somasundaram K., el-Deiry W.S. AP2 inhibits cancer cell growth and activates p21WAF1/CIP1 expression. Nat Genet. 15:1997;78-82
12. Moser M., Pscherer A., Roth C., et al. Enhanced apoptotic cell death of renal epithelial cells in mice lacking transcription factor AP-2beta. Gene Dev. 11:1997;1938-1948
13. Moser M., Ruschoff J., Buettner R. Comparative analysis of AP-2α and AP-2β gene expression during murine embryogenesis. Dev Dynam. 208:1997;115-124
14. Guinan P., Sobin L.H., Algaba F., et al. for the Union International Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC) TNM staging of renal cell carcinoma: Workgroup No. 3. Cancer. 80:1997;992-993
15. Oyama N., Iwatsuki K., Homma Y., et al. Induction of transcription factor AP-2 by inflammatory cytokines in human keratinocytes. J Invest Dermatol. 113:1999;600-606
16. Mitchel P.J., Timmons P.M., Hébert J.M., et al. Transcription factor AP-2 is expressed in neural crest cell lineages during mouse embryogenesis. Gene Dev. 5:1991;105-119
17. Storkel S., Eble J.N., Adlakha K., et al. for the Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC) Classification of renal cell carcinoma: Workgroup No. 1. Cancer. 80:1997;987-989
18. Wright C., Nicholson S., Angus B., et al. Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer. Br J Cancer. 65:1992;118-121
19. Latif Z., Watters A.D., Bartlett J.M.S., et al. Gene amplification and overexpression of HER2 in renal cell carcinoma. BJU Int. 89:2002;5-9
20. Vernimmen D., Gueders M., Pisvin S., et al. Different mechanisms are implicated in ERBB2 gene overexpression in breast and in other cancers. Br J Cancer. 89:2003;899-906
21. Matsushita K., Kobayashi S., Kato M., et al. Reduced messenger RNA expression level of p21 CIP1 in human colorectal carcinoma tissues and its association with p53 gene mutation. Int J Cancer. 69:1996;259-264
22. Ogawa M., Maeda K., Onoda N., et al. Loss of p21WAF1/CIP1 expression correlates with disease progression in gastric carcinoma. Br J Cancer. 75:1997;1617-1620